Navigation Links
Royalty Pharma Announces Offer May Lapse (Be Withdrawn)
Date:6/13/2013

omit anything likely to affect the import of such information.

The managing member of RP Management accepts responsibility for the information contained in this announcement, save that the only responsibility accepted by the managing member of RP Management in respect of the information in this announcement relating to Elan, the Elan Group, the Board of Elan and the persons connected with them, which has been compiled from published sources, has been to ensure that such information has been correctly and fairly reproduced or presented (and no steps have been taken by the managing member of RP Management to verify this information). To the best of the knowledge and belief of the managing member of RP Management (having taken all reasonable care to ensure that such is the case), the information contained in this announcement for which he accepts responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

Other

J.P. Morgan, together with its affiliate J.P. Morgan Cazenove (which is authorised and regulated by the Financial Conduct Authority in the United Kingdom), is acting exclusively for Royalty Pharma and RP Management in connection with the matters described in this announcement and for no one else, and is not, and will not be, responsible to anyone other than Royalty Pharma and RP Management for providing the protections afforded to clients of J.P. Morgan or its affiliates, or for providing advice in relation to the Further Increased Offer or any other matters referred to in this announcement.

BofA Merrill Lynch, together with its affiliate Merrill Lynch International (which is authorised and regulated by the Financial Conduct Authority in the United Kingdom), is acting exclusively for Royalty Pharma and RP Management in connection with the matters described in this announcement and for no one else, and is not, and will no
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
2. Royalty Pharma Files Judicial Review Proceedings
3. Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan
4. Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
5. Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
6. Royalty Pharma Acceptances Announcement
7. Royalty Pharma Responds To Elans Tysabri Valuation
8. Royalty Pharma Response To Elans "Categorical View On Value"
9. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
10. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
11. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... announced today that it will host a conference call ... results for the period ended March 31, 2015 and ... to its clinical program for aramchol. ...
(Date:5/6/2015)... 2015 According to a ... Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, ... Kits, Reagents, Resins) by Application & End User ...  the global Protein Purification and Isolation Market was ... is expected to reach $ 6,370 Million by ...
(Date:5/6/2015)... 2015   Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... announced a $50,000 product donation to the Reproducibility ... key findings from recent high-impact papers in the field ... the online research marketplace Science Exchange , the ... open-access journal eLife. The goal of the ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3
... VR Laboratories LLC today announced the appointment ...  Rothman will head scientific research and development for ... market world-class botanical consumer, medicinal food and beverage, ... In addition to assisting in product development, Rothman ...
... 2011 Seven Summits Research issues critical PriceWatch Alerts for ... what our analysts have discovered about these stocks read the ... (Note: You may have to copy this link into your ... Alerts cover the following stocks: Barrick Gold Corporation (NYSE: ...
Cached Medicine Technology:James Rothman Named Chief Scientific Advisor at VR Laboratories 2James Rothman Named Chief Scientific Advisor at VR Laboratories 3James Rothman Named Chief Scientific Advisor at VR Laboratories 4Critical Alerts For Barrick Gold, Molycorp, Lockheed Martin, Teva Pharmaceutical, and Tenaris Released By Seven Summits Research 2
(Date:5/6/2015)... 06, 2015 TMG Health, the leading ... Medicare Advantage, Medicare Part D and Managed Medicaid markets, ... Resilience Team category at the BCI North America Awards, ... recognize the outstanding contribution of business continuity professionals and ... Region, including the USA and Canada. The North America ...
(Date:5/6/2015)... Los Angeles (PRWEB) May 06, 2015 ... WaterAid, the #1 ranked international water, sanitation and hygiene ... work for communities across the world and it brings ... Lindsey Carnett, CEO of Marketing Maven. “The ongoing relationship ... the opportunities available for people to learn about and ...
(Date:5/6/2015)... May 06, 2015 Vancouver Chiropractic ... shared their new blog containing the Canadian Physical ... the Canadian Society for Exercise Physiology (CSEP). Since ... activity, health and fitness research and personal training ... exercise are highly beneficial and a rich resource ...
(Date:5/6/2015)... May 06, 2015 Healthcare jobs ... mark after launching in mid-February. The company connects hospitals, ... have previous experience in the industry. Likewise, job seekers ... According to Kyle Johnson, CTO, unique traffic to the ... first month: "Each new job posting brings targeted, interested ...
(Date:5/6/2015)... Chandler, AZ (PRWEB) May 06, 2015 ... now open for League Corporate Partner booth selection ... products and services to community college and university decision-makers ... take place November 1-4, 2015, at the Arizona Grand ... a private desert oasis on the doorstep of the ...
Breaking Medicine News(10 mins):Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2
... that has enhanced public understanding of biomedical researchWASHINGTON, ... (FBR) announced today it is accepting entries for ... The awards, named after FBR,s late chairman, ... reporting has enhanced public understanding of how the ...
... April 3 AstraZeneca (NYSE: AZN ) ... Drug Administration (FDA) posted to its web site -- ... 8, 2009 Psychopharmacologic Drugs Advisory Committee (PDAC) meeting. The ... efficacy data provided in supplemental new drug applications (sNDA) ...
... researchers say , , FRIDAY, April 3 (HealthDay News) -- ... insights into multiple sclerosis and other afflictions of the ... looking into why pregnant cats on a special diet ... including paralysis and vision, University of Wisconsin-Madison researchers found ...
... stock jeopardize shareholder interests?TEQUESTA, Fla., April 3 In ... and the Board of Directors of Energy Partners, LTD ... (CCC), personally holding a quarter million shares as well ... concern over a proposed bond buyout of the company,s ...
... Pass Bill to Protect Patient Access WASHINGTON, April 3 ... osteoporosis testing and reduce the physical and economic burden ... "Medicare Fracture Prevention and Osteoporosis Testing Act of 2009," ... and Olympia Snowe (R-ME) introduced the Senate version and ...
... 3 First Choice Professionals, LLC., today announced the ... Health Integration Solution ( THIS ). ... has joined forces with TIBCO Software Inc. (Nasdaq: ... brokering, SOA integration, and complex event processing. The partnership ...
Cached Medicine News:Health News:Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 3Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 4Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 5Health News:Cat Food-Linked Illness Yields Clues to MS 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 3Health News:Access to Osteoporosis Testing for Americans in Jeopardy 4Health News:Access to Osteoporosis Testing for Americans in Jeopardy 5Health News:FCP Announces Total Healthcare Integration Solution (THIS) Powered by TIBCO 2
... Visionblue is a staining solution for ... required for performing a safe phaco-emulsification ... lens capsule may result in an ... risk of radial capsule tears and ...
Rhex-ID (Trypan Blue 0.8 mg)....
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Auto refractometer....
Medicine Products: